Mednax Inc Stock Annual Yield
MD Stock | USD 14.41 0.22 1.55% |
Mednax Inc fundamentals help investors to digest information that contributes to Mednax's financial success or failures. It also enables traders to predict the movement of Mednax Stock. The fundamental analysis module provides a way to measure Mednax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednax stock.
Mednax | Annual Yield |
Mednax Inc Company Annual Yield Analysis
Mednax's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Mednax Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Mednax is extremely important. It helps to project a fair market value of Mednax Stock properly, considering its historical fundamentals such as Annual Yield. Since Mednax's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mednax's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mednax's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Mednax Inc has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Mednax Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednax's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mednax could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics of similar companies.Mednax is currently under evaluation in annual yield category among its peers.
Mednax ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.Environmental | Governance | Social |
Mednax Fundamentals
Return On Equity | -0.3 | ||||
Return On Asset | 0.0467 | ||||
Profit Margin | (0.13) % | ||||
Operating Margin | 0.10 % | ||||
Current Valuation | 1.68 B | ||||
Shares Outstanding | 85.88 M | ||||
Shares Owned By Insiders | 1.68 % | ||||
Shares Owned By Institutions | 98.32 % | ||||
Number Of Shares Shorted | 2.39 M | ||||
Price To Earning | 89.39 X | ||||
Price To Book | 1.66 X | ||||
Price To Sales | 0.61 X | ||||
Revenue | 1.99 B | ||||
Gross Profit | 426.98 M | ||||
EBITDA | 29.89 M | ||||
Net Income | (60.41 M) | ||||
Cash And Equivalents | 9.82 M | ||||
Cash Per Share | 1.29 X | ||||
Total Debt | 701.65 M | ||||
Debt To Equity | 1.03 % | ||||
Current Ratio | 1.39 X | ||||
Book Value Per Share | 8.67 X | ||||
Cash Flow From Operations | 137.32 M | ||||
Short Ratio | 3.10 X | ||||
Earnings Per Share | (2.34) X | ||||
Price To Earnings To Growth | 0.88 X | ||||
Target Price | 16.36 | ||||
Number Of Employees | 5.45 K | ||||
Beta | 1.56 | ||||
Market Capitalization | 1.22 B | ||||
Total Asset | 2.22 B | ||||
Retained Earnings | (149.47 M) | ||||
Working Capital | 94.51 M | ||||
Current Asset | 527.77 M | ||||
Current Liabilities | 428.77 M | ||||
Net Asset | 2.22 B |
About Mednax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednax Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednax Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Mednax Piotroski F Score and Mednax Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.34) | Revenue Per Share | Quarterly Revenue Growth 0.009 | Return On Assets |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.